tiprankstipranks
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
Holding ANIP?
Track your performance easily

ANI Pharmaceuticals (ANIP) Ownership - Who Owns ANI Pharmaceuticals?

284 Followers

ANI Pharmaceuticals (ANIP) Ownership Overview

10.13%18.15%23.68%22.54%25.50%
10.13% Insiders
23.68% Other Institutional Investors
22.54% ETFs
25.50% Public Companies and
Individual Investors
The ownership structure of ANI Pharmaceuticals (ANIP) stock is a mix of institutional, retail, and individual investors. Approximately 64.37% of the company’s stock is owned by Institutional Investors, 10.13% is owned by Insiders, and 25.50% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 18, 2024
Christopher Mutz
Head Of Rare Disease
xxxxxxxxxxxxx
$375050
Jun 06, 2024
xxxxxxxxxxxxx
$317900
Jun 06, 2024
Ori Gutwerg
Svp, Generics
xxxxxxxxxxxxx
$199995
May 22, 2024
Christopher Mutz
Head Of Rare Disease
xxxxxxxxxxxxx
$123220

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,047,084Institution9.74%114,002,108
1,081,576Institution5.15%60,232,967
831,537Institution3.96%46,308,296
706,272Insider3.36%39,332,288
557,611Institution2.65%31,053,357
373,859Insider1.78%20,820,208
350,387Institution1.67%19,513,052
326,067Institution1.55%18,158,671
313,704Institution1.49%17,470,176
263,159Institution1.25%14,655,325

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
831,537Institution3.96%46,308,296
350,387Institution1.67%19,513,052
326,067Institution1.55%18,158,671
263,159Institution1.25%14,655,325
206,405Institution0.98%11,494,694
194,910Institution0.93%10,854,538
162,932Institution0.78%9,073,683
154,168Institution0.73%8,585,616
115,708Institution0.55%6,443,779
113,437Institution0.54%6,317,307

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,066,420Institution5.07%59,388,930
588,253Institution2.80%35,095,174
555,970Institution2.65%31,456,783
501,234Institution2.38%27,913,721
245,955Institution1.17%14,673,675
160,607Institution0.76%8,944,204
149,362Institution0.71%8,252,251
146,425Institution0.70%8,089,981
116,647Institution0.55%6,496,071
84,827Institution0.40%5,060,779

FAQ

Who Owns ANI Pharmaceuticals Inc (ANIP)?
According to the latest TipRanks data, approximately 23.68% of the company's stock is held by institutional investors, 10.13% is held by insiders, and 25.50% is held by retail investors.
    What percentage of ANI Pharmaceuticals Inc (ANIP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 23.68% of ANI Pharmaceuticals Inc (ANIP) stock is held by institutional investors.
      What percentage of ANI Pharmaceuticals Inc (ANIP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 25.50% of ANI Pharmaceuticals Inc (ANIP) stock is held by retail investors.
        Who owns the most shares of ANI Pharmaceuticals Inc (ANIP)?
        iShares owns the most shares of ANI Pharmaceuticals Inc (ANIP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis